Cibc World Market Inc. Nektar Therapeutics Transaction History

Cibc World Market Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$15.87 - $23.12 $451,612 - $657,925	-28,457 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $24,232 - $51,974	-1,433 Reduced 4.79%	28,457 $518,000
Q2 2019 Aug 08, 2019	SELL	$31.0 - $36.3 $17,391 - $20,364	-561 Reduced 1.84%	29,890 $1.06 Million
Q1 2019 May 09, 2019	BUY	$31.58 - $46.35 $2,936 - $4,310	93 Added 0.31%	30,451 $1.02 Million
Q4 2018 Feb 13, 2019	BUY	$30.43 - $56.65 $923,793 - $1.72 Million	30,358 New	30,358 $998,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.